John W Barrett Selected Research

John W Barrett Research Topics

Disease

37	Neoplasms (Cancer) 01/2022 - 11/2005
21	Squamous Cell Carcinoma of Head and Neck 03/2022 - 01/2012
11	Infections 09/2009 - 05/2003
6	Head and Neck Neoplasms (Head and Neck Cancer) 10/2021 - 11/2014
3	Anaplastic Thyroid Carcinoma 01/2020 - 01/2014
3	Carcinogenesis 10/2019 - 04/2014
3	Squamous Cell Neoplasms (Squamous Cell Cancer) 09/2017 - 09/2014
3	Myxoma (Myxomas) 09/2014 - 02/2007
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 04/2012
2	Pain (Aches) 01/2022 - 01/2014
2	Oropharyngeal Neoplasms 01/2022 - 11/2020
2	Fibrosis (Cirrhosis) 12/2021 - 01/2020
2	Carcinoma (Carcinomatosis) 08/2019 - 10/2017
2	Vaccinia 09/2014 - 01/2014
2	Inflammation (Inflammations) 10/2009 - 12/2005
2	Neoplasm Metastasis (Metastasis) 01/2008 - 09/2007
1	Chronic Pain 01/2022
1	Opioid-Related Disorders (Opiate Addiction) 01/2022
1	Thyroid Nodule (Nodule, Thyroid) 01/2021
1	Hypoxia (Hypoxemia) 12/2020
1	Neutropenia 11/2020
1	Deglutition Disorders (Dysphagia) 11/2020
1	Ototoxicity 11/2020
1	Disease Progression 01/2020
1	Idiopathic Pulmonary Fibrosis 01/2020
1	Wounds and Injuries (Trauma) 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2015
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2012
1	Tonsillar Neoplasms 01/2012

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 10/2021 - 05/2005
6	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2012
5	NucleotidesIBA 10/2021 - 01/2019
5	Messenger RNA (mRNA)IBA 02/2021 - 10/2017
4	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 01/2012
4	RNA (Ribonucleic Acid)IBA 10/2021 - 07/2008
4	Phosphotransferases (Kinase)IBA 01/2008 - 05/2003
3	CytokinesIBA 12/2021 - 12/2005
3	IntegrinsIBA 12/2021 - 10/2009
3	Pharmaceutical PreparationsIBA 09/2017 - 11/2014
3	Sirolimus (Rapamycin)FDA Link 01/2008 - 02/2007
2	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2021
2	Bleomycin (Blenoxane)FDA LinkGeneric 12/2021 - 01/2020
2	CollagenIBA 12/2021 - 01/2020
2	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2021 - 01/2020
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2020 - 09/2007
2	Mechanistic Target of Rapamycin Complex 2IBA 01/2020 - 10/2019
2	Phosphatidylinositols (Phosphatidylinositol)IBA 10/2019 - 06/2013
2	Interferon-gamma (Interferon, gamma)IBA 08/2019 - 05/2003
2	Codon (Codons)IBA 01/2016 - 06/2013
2	ErbB Receptors (EGF Receptor)IBA 09/2014 - 04/2012
2	Antiviral Agents (Antivirals)IBA 04/2009 - 01/2008
2	Interferon Type IIBA 07/2008 - 12/2004
1	Morphine (MS Contin)FDA LinkGeneric 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	human MIRN421 microRNAIBA 10/2021
1	ProteomeIBA 10/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2021
1	PlatinumIBA 02/2021
1	Circulating Tumor DNAIBA 01/2021
1	AlpelisibIBA 10/2020
1	ChemokinesIBA 01/2020
1	Blocking AntibodiesIBA 01/2020
1	GSK3008348IBA 01/2020
1	maleic acid (maleate)IBA 01/2020
1	Syk KinaseIBA 01/2020
1	alvocidib (flavopiridol)IBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 10/2019
1	Viral AntigensIBA 01/2018
1	lestaurtinibIBA 01/2018
1	Oncogene Proteins (Oncogene Protein)IBA 10/2017
1	InterferonsIBA 10/2017
1	Adenosine Monophosphate (AMP)IBA 10/2017
1	Histocompatibility Antigens Class IIBA 10/2017
1	I-antigenIBA 10/2017
1	Albendazole (Albenza)FDA Link 09/2017
1	Cyclin-Dependent Kinase Inhibitor p16IBA 09/2017
1	Histones (Histone)IBA 02/2017
1	LDL Receptors (LDL Receptor)IBA 01/2015
1	Docetaxel (Taxotere)FDA Link 11/2014
1	Gefitinib (Iressa)FDA Link 11/2014
1	bosutinibIBA 11/2014
1	AfatinibIBA 11/2014
1	2- (1- (7- methyl- 2- morpholin- 4- yl- 4- oxo- 4H- pyrido(1,2- a)pyrimidin- 9- yl)ethylamino)benzoic acidIBA 11/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2014
1	Fibronectins (Fibronectin)IBA 04/2014
1	Notch ReceptorsIBA 08/2012
1	Tyrosine Kinase InhibitorsIBA 06/2010
1	GenisteinIBA 06/2010
1	Virulence Factors (Pathogenicity Factors)IBA 09/2009
1	Tyrosine (L-Tyrosine)FDA Link 04/2009
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2009

Therapy/Procedure

13	Therapeutics 01/2022 - 09/2007
3	Radiotherapy 01/2022 - 04/2012
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2020
3	Oncolytic Virotherapy 11/2007 - 02/2007
1	Gastrostomy 11/2020
1	Neoadjuvant Therapy 10/2019
1	Immunotherapy 01/2018
1	Precision Medicine 01/2014